The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / The Little-Known (But Not Uncommon) SSc-Lupus Overlap Syndrome

The Little-Known (But Not Uncommon) SSc-Lupus Overlap Syndrome

May 18, 2019 • By Susan Bernstein

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Skin plaques in systemic sclerosis.

Skin plaques in systemic sclerosis.
SPL / Science Source

What happens when systemic sclerosis (SSc) overlaps with other systemic autoimmune rheumatic diseases? Patients with either diffuse cutaneous or limited cutaneous SSc sometimes develop systemic lupus erythematosus (SLE) as well. A new, large cohort study published in the Journal of Rheumatology reveals details on the epidemiology, clinical signs and survival data of SSc-SLE overlap syndrome.1

You Might Also Like
  • Opinion: Erosive Changes Questioned in RA/Lupus Overlap Syndrome
  • ACR Issues sJIA Recommendations, SSc Classification Criteria
  • Critieria, Pathogenesis Highlight New Lupus Efforts
Explore This Issue
May 2019
Also By This Author
  • ACR Urges CMMI to Test Transparently: Coalition offers principles to guide CMS’s care innovation efforts

“Little is known on this group of patients, and it is important to shed light on their prevalence and characteristics,” says Sindhu R. Johnson, MD, PhD, director of the Toronto Scleroderma Project at the University of Toronto, Canada, and a study co-author. “The field of overlap syndromes has been challenging for clinicians. There is a lack of understanding and knowledge about what overlap means in terms of potential complications and prognosis. We do not have clearly specified diagnostic criteria or classification criteria to systemically identify these people.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Past evidence shows SSc-SLE overlap patients more frequently present with Raynaud’s phenomenon and such complications as discoid lupus, lupus nephritis, pancreatitis, avascular bone necrosis and shrinking lung syndrome.2-6 Evidence also shows anti-U1RNP antibodies are more frequent in SSc-SLE overlap syndrome, and this study revealed more important serological markers.7 Anti-RNP or anti-U1RNP may be useful screening tests for SSc overlap syndromes, says Dr. Johnson.

Young, Female, Asian

The study’s cohort included subjects from the Toronto Scleroderma Program (a network of three academic hospitals) who fulfilled the ACR/European League Against Rheumatism (EULAR) classification criteria for SSc and/or the ACR classification criteria for SLE.8-10 The primary outcome was time from diagnosis to all-cause mortality. Patients were followed every 6–12 months using a standardized protocol. The study period ran from 1970–2017.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Out of 1,252 subjects, the researchers identified 1,116 with SSc only and 86 with SSc-SLE overlap syndrome, a prevalence of 6.8%. The overlap syndrome subjects were 92% female and 10 years younger at diagnosis than SSc patients who did not have SLE (a mean age of 37.9 vs. 47.9 years). In addition, compared with SSc patients without SLE, overlap syndrome patients in the study were more commonly of East Asian or South Asian ancestry.

Compared with SSc patients without SLE, overlap syndrome patients more frequently had lupus anticoagulant, anti-cardiolipin antibodies and pulmonary arterial hypertension (PAH). Less frequently, overlap patients had calcinosis, telangiectasia and diffuse subtype. The study found no significant differences between the two groups when it came to the occurrence of renal crisis, interstitial lung disease (ILD) or digital ulcers.

Patients in the two groups had no significantly different occurrences of comorbidities like hypertension, diabetes, dyslipidemia, cancer, stroke or atrial fibrillation. All of the SSc-SLE overlap syndrome patients had anti-dsDNA or anti-Sm antibodies.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

No survival data had been reported for SSc-SLE overlap syndrome before this study. There were 432 deaths recorded during the follow-up, including 411 subjects with SSc alone and 21 with SSc-SLE overlap. Overlap syndrome patients had a better, but not statistically significant, difference in mean survival time: 26.1 years compared with 22.4 years for patients with SSc alone. Overlapping SLE neither increases the risk of, nor offers any protective effect against, mortality, the study found.

Pages: 1 2 3 | Single Page

Filed Under: Conditions, Scleroderma, SLE (Lupus) Tagged With: Classification Criteria, overlap, systemic sclerosis (SSc)Issue: May 2019

You Might Also Like:
  • Opinion: Erosive Changes Questioned in RA/Lupus Overlap Syndrome
  • ACR Issues sJIA Recommendations, SSc Classification Criteria
  • Critieria, Pathogenesis Highlight New Lupus Efforts
  • Researchers Release Proposed Lupus Criteria, & Pathogenesis Findings

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.